Delivery Order SPE2DB22D2007-SPE2DB23FJ3KN

Award Date 6/20/23
Potential Completion Date 6/21/23
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $62,130 delivery order to Amerisourcebergen Drug Corporation for Imatinib Mesylate 100mg tablets. Under this firm fixed price contract, Amerisourcebergen will provide 90 tablets of the generic cancer drug to an address in Conshohocken, Pennsylvania by June 28, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen frequently receives delivery orders under the DLA's Prime Vendor program to support the medical readiness...
The Defense Logistics Agency awarded a $645.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of 400mg Imatinib Mesylate to be delivered to its Conshohocken, Pennsylvania facility by July 21, 2023. As a major pharmaceutical distributor, Amerisourcebergen will fulfill this order from the Defense Logistics Agency, which manages the Department of Defense's global supply chain, to supply this cancer treatment drug in support of DOD health programs. No set...
The Defense Logistics Agency awarded a $499 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400mg Imatinib Mesylate tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, fulfilling the agency's requirements under the contract which runs from July 25 to July 26, 2023. The Defense Logistics Agency leverages strategic sourcing vehicles to procure pharmaceuticals and medical supplies in support of its...
The Defense Logistics Agency awarded a $242,070 firm fixed price delivery order to AmerisourceBergen Drug Corporation for 30 boxes of 400mg Imatinib Mesylate tablets. The place of performance is AmerisourceBergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 20-21, 2023. This delivery order was issued against an existing DLA pharmaceutical supply vehicle to fulfill requirements for oncology medications in support of DOD health programs. No set aside...
Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $4,433.72 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to supply 400mg Imatinib Mesylate tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The contract period of performance spans October 21 to October 22, 2021. No subcontractors or set aside designations were identified. This delivery order was issued against an...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred dollars and eighty-two cents to Amerisourcebergen Drug Corporation for the supply of thirty tablets of 400mg Imatinib Mesylate. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania to the Defense Logistics Agency. The single day period of performance spans from August 28, 2023 through August 29,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,242.05 Firm Fixed Price Delivery Order is for the supply of 4,558,265,473 units of Imatinib Mesylate 100 mg tablets. The contract has an ultimate completion date of August 30, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,396.48 firm fixed-price delivery order is for the supply of 4,556,266,791 units of Imatinib Mesylate 100 mg tablets, with a completion date of February 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract has no set-aside...
The Defense Logistics Agency awarded a $645.52 delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 30 tablets of 400mg Imatinib Mesylate. The prime contractor will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania under a firm fixed price contract running from August 14-15, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the U.S. military and...
The Defense Logistics Agency awarded a $804.60 delivery order to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 100mg Imatinib Mesylate. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility under a firm fixed price contract. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the United States military and supports numerous procurement programs...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB23FJ3KN
    Delivery Order

The Defense Logistics Agency awarded a $1,194 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400mg Imatinib Mesylate tablets. Under this order, Amerisourcebergen will deliver 30 tablets of the generic cancer drug to an address in Conshohocken, Pennsylvania by June 21, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen likely supports DLA's mission to provide medical supplies and equipment to military treatment facilities worldwide. No set aside designation or subcontractors were identified for this small, short-term order valued at approximately $1,200 to fulfill an immediate need for this prescription medication.

Generated 12/17/23, 10:37 PM